août 22 2024
MAYER BROWN ADVISES SOCIÉTÉ DES PRODUITS NESTLÉ ON ACQUISITION AND EQUITY INVESTMENT
Mayer Brown represented Société des Produits Nestlé S.A., a subsidiary of Nestlé S.A., in (i) the purchase of substantially all of the assets of Seres Therapeutics, Inc.'s VOWST microbiome therapeutic business, in consideration for an up-front payment of $235 million, plus additional milestone payments aggregating $275 million depending on the achievement of specified sales milestones and (ii) a related $15 million equity investment.
The team was led by partner David Carpenter and associates Karen Chong, Nina Cao, Natalie Kim, and Charles Abraham.
The team was led by partner David Carpenter and associates Karen Chong, Nina Cao, Natalie Kim, and Charles Abraham.